Lexaria Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Lexaria Corp. (Lexaria Bioscience Corp.) on March 12, 2014. The report discloses the entry into a material marketing agreement and the unregistered sale of equity securities to fund said agreement.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The specific financial activity disclosed is a $50,000 marketing agreement payable entirely in common stock.
- Agreement Value: $50,000 total over 12 months.
- Initial Payment: $12,500 (25% of total).
- Shares Issued (Q1): 20,833 common shares.
- Implied Share Price: $0.60 per share.
Material Changes
The primary material change is the issuance of 20,833 shares to Agora Internet Relations Corp. for the first quarter of a 12-month marketing contract. This transaction was conducted as an offshore transaction pursuant to Regulation S, exempt from registration under the Securities Act of 1933.
Outlook, Risks, and Unusual Items
Management Commentary: The company entered the agreement to secure extensive online marketing deliverables, including 10 million embedded ads, exclusive sponsorships on AGORACOM platforms, and search engine awareness programs.
Risks and Contingencies: The securities issued were not registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption. The transaction relied on the representation that the subscriber was not a "US person."
Investor Verification Checklist
- Verify the current market price of Lexaria common stock to assess the dilution impact of the 20,833 shares issued.
- Confirm the total number of shares authorized for issuance over the full 12-month term of the $50,000 agreement.
- Review the attached news release (Exhibit 99.1) for specific performance metrics expected from the marketing campaign.
- Check subsequent filings for the issuance of the remaining three quarterly payments in stock.